{
  "compound": "Nabilone (Cesamet)",
  "condition": "NAUSEA_CHEMOTHERAPY",
  "effect_size": "Large (Cohen's d = 0.98)",
  "study_type": "RCT",
  "source": "NORML:CINV_RCT_002",
  "participants": "88 patients receiving highly emetogenic chemotherapy",
  "year": 2015,
  "notes": "Nabilone for Delayed Chemotherapy-Induced Nausea: Randomized Trial",
  "confidence": "medium",
  "abstract": "Nabilone: 68% reduction in delayed nausea vs Placebo: 31% reduction; p<0.001; NNT = 3 for clinically meaningful improvement"
}